Search

Search Constraints

You searched for: Author/Creator Ren, Shuang

Search Results

26. Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment study using biomarker‐guided patient selection. Issue 9 (30th May 2018)

27. Dynamic Between-Leg Differences While Walking in Anterior Cruciate Ligament–Deficient Patients With and Without Medial Meniscal Posterior Horn Tears. Issue 5 (22nd May 2020)

28. Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator. Issue 2 (11th November 2021)